Recombinant SARS-CoV-2 Nucleocapsid Protein produced in E.coli is a Recombinant His-tagged protein.
Recombinant SARS-CoV-2 Nucleocapsid Protein
SARS-CoV-2 nucleocapsid (N) protein is an important antigen for coronavirus, which participates in RNA package and virus particle release.
Nucleocapsid protein packages the positive strand viral RNA genome into a helical interactions with the viral genome and the small membrane protein M. It plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Nucleocapsid protein may modulate the transforming growth factor-beta signalling by binding host smad3.
|Application||Clinical diagnostics| Life Sciences|
|Product type||Reagents for research|
|Reagent type||Recombinant protein|
|Accession number||UniProt QHD43423.2|
|Potency||Not biologically Active protein|
|Shipping/storage conditions||Shipped on dry ice. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles|
|Usage||For Laboratory research only|
|A new coronavirus associated with human respiratory disease in China.||PUMED ID: 32015508|
|Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites.||PUBMED ID: 32363136|
|Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein.||PUBMED ID: 32511359|